PATENT CLAIM ANALYSIS

Application Number: 15882400
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "094100"]

Abstract:
The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.

Claim (Index 20):
The method of  claim 19 , wherein the collagen-containing tissue matrix is a particulate matrix, and wherein attaching the collagen-containing tissue matrix to the synthetic substrate comprises applying a slurry of the collagen-containing tissue matrix to the synthetic substrate.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 86.0
- Lexical Diversity: 1.41667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13813814', '12231361', '10895961', '14696390', '13517906']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.705623904486002
- 35 USC 102 Novelty (BERT): 0.4831925826349702
- Combined Prediction Score: 0.6833807723008989
- Mean Citation Score: 156.113868
- Max Citation Score: 162.29962
- Similarity Product: 111.48835233397485

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test